12 die of leptospirosis in Kerala

Published On 2018-09-04 04:03 GMT   |   Update On 2018-09-04 04:03 GMT

Kochi:  Twelve people have died of leptospirosis disease in Kerala between August 1 and September 3, while 372 confirmed leptospirosis cases have been reported from the flood-hit state since August 1.


In lieu of the outbreak, Kerala Health Minister K. K. ShailajaTeacher called a review meeting at Kozhikode, the district from where the most number of leptospirosis cases have been reported.

After the review meeting, the health minister announced three weeks of high alert and said, "Kerala would be on high alert for next three weeks but there is nothing to panic. All hospitals are equipped with enough stocks of medicine. Even though there were wide advisories after the flood, people were reluctant to consume precautionary tablets. As more cases have been reported from Kozhikode district, an isolated war-room will be set up in Kozhikode medical college."

Leptospirosis is a bacterial disease that affects both humans and animals. It infects human when they come in direct contact with the urine of infected animals or with a urine-contaminated environment. Some of the early symptoms of the disease include high fever, muscle pain, headache, redness of the eye, vomiting, diarrhoea among others.

Kerala was recently hit by the worst floods in nearly a century, which claimed lives of more than 400 people and caused damage to the tune of nearly Rs. 20,000 crores.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News